The Lancet: Journal Homepage
WEB4 days ago · The growing challenge of antimicrobial resistance (AMR) is now recognised as a global public health emergency that requires concerted efforts by all stakeholders. 1 There is compelling evidence that AMR is associated with increased mortality and longer hospitalisation, and has a negative effect on the economies of communities and countries, more so in low-income and middle-income countries ...
Global Burden of Disease - The Lancet
WEBWelcome to the Lancet Global Burden of Disease (GBD) Resource Centre, bringing together the most comprehensive data and analysis of worldwide trends in global health, published across the Lancet family of journals. All GBD Articles published with the Lancet journals are Open Access or otherwise free to read with registration.
The Lancet Oncology
WEB5 days ago · In 2015, the Lancet Oncology Commission on Global Cancer Surgery focused on access to safe, affordable, and timely cancer surgery worldwide. It highlighted cancer surgery as integral to national cancer control plans and critically examined the state of global cancer surgery and changes in policy that might drive improvements in research, education, and systems of care across all income settings.
The Lancet Gastroenterology and Hepatology: Homepage
WEB3 days ago · The efforts of institutions in promoting diversity and inclusion without equity and justice have been described as ornamental and performative. 1 Organisations and institutions in the field of gastroenterology and hepatology are not exempt from these assertions. Although often well meaning, these initiatives usually represent meagrely impactful attempts by medical institutions to narrow ...
eClinicalMedicine Home Page - The Lancet
WEB2 days ago · Riccardo De Giorgi joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that semaglutide may be associated with a reduced risk of a number of neurological and psychiatric outcomes, including cognitive deficits and dementia, as well as nicotine misuse. Read associated article. (mp3, 32:50mins,26.3MB)
The Lancet Infectious Diseases Home Page
WEB2 days ago · Prasad Kulkarni on a dengue monoclonal antibody. Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development. Read associated article.
The Lancet Haematology Home Page
WEBSep 9, 2024 · In The Lancet Haematology, Gordon Cook and colleagues 1 report the results of a planned interim analysis of the multicentre, randomised, phase 3 ACCoRD trial done in the UK by the Myeloma Research Council. The trial aims to assess whether consolidation with ixazomib, thalidomide, and dexamethasone followed by maintenance with ixazomib is superior to observation after autologous haematopoietic ...
Global burden of bacterial antimicrobial resistance in 2019: a ...
WEBFeb 12, 2022 · To our knowledge, this study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of the availability of data. AMR is a leading cause of death around the world, with the highest burdens in low-resource settings. Understanding the burden of AMR and the leading pathogen–drug combinations contributing to it is crucial to making informed and location ...
Chronic pain: an update on burden, best practices, and new …
WEBChronic pain exerts an enormous personal and economic burden, affecting more than 30% of people worldwide according to some studies. Unlike acute pain, which carries survival value, chronic pain might be best considered to be a disease, with treatment (eg, to be active despite the pain) and psychological (eg, pain …
Lung cancer - The Lancet
WEBJul 14, 2021 · Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial improvements in our understanding of disease biology, application of predictive biomarkers, and refinements in treatment have led to remarkable progress in the past two decades and transformed ...